Cell therapies for glioblastoma (Q36541937)

14 August 2017

1 reference

title

Cell therapies for glioblastoma (English)

1 reference

14 August 2017

5

Rolf Bjerkvig

1 reference

14 August 2017

A Jorge A Terzis

1

1 reference

14 August 2017

Simone P Niclou

series ordinal

2

1 reference

14 August 2017

Uros Rajcevic

series ordinal

3

1 reference

14 August 2017

Claude Danzeisen

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Expert Opinion on Biological Therapy

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

8

1 reference

14 August 2017

739-749

1 reference

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Gene therapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Transgenic and gene disruption techniques in the study of neurocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Insights into cancer from transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

An athymic nude mutation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Growth of precultured human glioma specimens in nude rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Genetic strategies for brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Viral therapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Retroviral transfection of the lacZ gene from Liz-9 packaging cells to glioma spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Search and destroy: recent research exploits adult stem cells' attraction to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Neural stem and progenitor cells: a strategy for gene therapy and brain repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Progress in active-specific immunotherapy of brain malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Monoclonal antibodies for brain tumour treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Cytokine gene therapy for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Cell therapies in neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Adoptive-cell-transfer therapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Encapsulated Islets in Diabetes Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Alginate as immobilization matrix for cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Local endostatin treatment of gliomas administered by microencapsulated producer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Gene therapy of experimental brain tumors using neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Neural progenitor cell lines inhibit rat tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Epidermal growth factor receptor and Ink4a/Arf

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.8.739

Spontaneous human adult stem cell transformation.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-04-4194

Identifiers

DOI

10.1517/14712598.6.8.739

1 reference

14 August 2017

1 reference